ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
6.01
-0.65 (-9.76%)
At close: May 12, 2025, 4:00 PM
6.01
0.00 (0.00%)
After-hours: May 12, 2025, 7:48 PM EDT
ReShape Lifesciences Employees
As of December 31, 2024, ReShape Lifesciences had 18 total employees, including 17 full-time and 1 part-time employees. The number of employees decreased by 13 or -41.94% compared to the previous year.
Employees
18
Change (1Y)
-13
Growth (1Y)
-41.94%
Revenue / Employee
$444,778
Profits / Employee
-$396,111
Market Cap
2.71M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RSLS News
- 15 hours ago - Orla Mining, ReShape Lifesciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
- 5 days ago - ReShape Lifesciences Announces 1-for-25 Reverse Stock Split - GlobeNewsWire
- 10 days ago - ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium - GlobeNewsWire
- 14 days ago - ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System - GlobeNewsWire
- 21 days ago - ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology - GlobeNewsWire
- 4 weeks ago - ReShape Lifesciences Inc. (RSLS) Earnings Highlights and Strategic Business Update Conference (Transcript) - Seeking Alpha
- 4 weeks ago - ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market - GlobeNewsWire
- 5 weeks ago - ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update - GlobeNewsWire